Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis
- 1 June 2005
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 341 (2) , 326-333
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteinsJournal of Inorganic Biochemistry, 2004
- Recent Developments in the Field of Tumor-Inhibiting Metal ComplexesCurrent Pharmaceutical Design, 2003
- Ruthenium metallopharmaceuticalsCoordination Chemistry Reviews, 2003
- Interactions of antitumoral platinum-group metallodrugs with albuminCoordination Chemistry Reviews, 2002
- Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free mediaJBIC Journal of Biological Inorganic Chemistry, 2001
- Binding of Antitumor Ruthenium(III) Complexes to Plasma ProteinsMetal-Based Drugs, 2000
- Medicinal Inorganic Chemistry1999
- New Anticancer Agents Developed by the New Drug Development Group (AWO)1999
- Comparison of the Antiproliferative Activity of Two AntitumourRuthenium(III) Complexes With Their Apotransferrin andTransferrin‐Bound Forms in a Human Colon Cancer Cell LineMetal-Based Drugs, 1995
- Protein‐binding Properties of two Antitumour Ru(III) Complexes toHuman Apotransferrin and ApolactoferrinMetal-Based Drugs, 1994